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With an increase in long term survival rates for childhood cancers, more focus is 
now being placed on quality of life issues resulting from long term side effects of 
treatment. Infertility in later life is a known side effect of chemotherapy in patients 
that have survived childhood cancer. The testis contains two irreplaceable cell 
populations for subsequent fertility, the proliferating stem germ cells and the 
somatic Sertoli cells that support the development of the germ cells.  First different 
methods to culture mouse testicular tissue were examined and then compared to in 
vivo time points to validate the model used. In order to examine which cell type is 
effected by exposure to chemotherapy, neonatal mouse testes were exposed to 
varying concentrations of either phosphoramide mustard (PM), cisplatin (CIS), or 
doxorubicin (DOX) on the second day of a four day in vitro culture (n ≥ 8 for each 
treatment). Immunofluorescent analysis showed that exposure to PM, CIS and DOX 
resulted in a specific loss of germ cells in the neonatal mouse testis at doses within 
the range found in patients’ serum. Finally, preliminary cultures using human foetal 
tissue were developed in order to compare the effects of chemotherapy between the 
mouse and human. In conclusion, the results presented here suggest that infertility 
following chemotherapy in childhood is due to a specific loss of germ cells from the 
seminiferous tubules.  




Survival rates for paediatric cancers have dramatically increased. The majority of 
these patients are treated with chemotherapy that has a mix of short and long term 
side effects. Infertility is a common side effect after chemotherapy. The childhood 
testis contains germ cells that will divide and produce sperm in later life and 
specialised support cells that aid in the development of the germ cells. Either of 
these cell populations could be damaged by chemotherapy and result in infertility 
in adulthood. 
 
We took pieces of mouse testis and exposed them to three chemotherapeutic agents 
phosphoramide mustard, cisplatin and doxorubicin at a range of concentrations that 
are found within the blood of patients undergoing chemotherapy. A range of 
markers for different cell types and for cell death were examined. When the tissue 
was exposed most of the germ cells were lost from the testis without a change in 
support cell number. The amount of cell death also increased but there was still very 
little in total.  
 
These results indicate that the three chemotherapy drugs studied here can cause a 
specific decrease in the germ cells in the neonatal mouse testis. This could result in 
infertility in later life.    
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Chapter 1. General introduction 
1.1 Embryonic testis development 
1.1.1 Testis formation  
The mammalian gonad forms from a bi-potential genital ridge that has the ability to 
differentiate into an ovary or testis (Koopman et al., 1991). The somatic cells and 
germ cells arise from different locations in the embryo. The support cells of the 
testis, the Sertoli cells develop from the surface of the coelomic epithelium (Karl and 
Capel, 1998). It is these differentiating Sertoli cells (pre-Sertoli cells), that initiate 
testicular development. Primordial germ cells migrate through the gut mesentery 
into the urogenital ridge to populate the gonad (Anderson et al., 2000), where they 
are enclosed in cords by the pre-Sertoli cells (Fig. 1.1). Germ cells are not required 
for cord formation; when they are depleted, seminiferous cords still form (Pellas et 
al., 1991, Merchant, 1975). Vascular endothelial cells aided by macrophages are also 
necessary as they migrate from the mesonephros and partition the cords (Fig 1.1; 
(Combes et al., 2009, DeFalco et al., 2014). Macrophages also aid the clearance of 
mislocated germ and Sertoli cells that have not made it into cords thus further 
aiding the partitioning of cords and interstitium (DeFalco et al., 2014). Peritubular 
myoid cells (PTMs) surround the Sertoli cells and form a basement membrane 
surrounding the seminiferous cords, separating the interstitial space from the 
tubules (Skinner et al., 1985).  
  




Figure 1.1 Formation of the foetal testis. Germ cells (green) migrate into the 
developing gonad while the Sertoli cells (purple) differentiate and aggregate around the 
germ cells. Vascular endothelial cells (red) migrate into the gonad between the cords and 
the FLCs (blue) differentiate and fill the interstitial compartment. Adapted from (Ross and 
Capel, 2005). 
1.1.2 Sex determination 
Sex determination is primarily driven by the presence or absence of the Y 
chromosome. In the male mouse, sry (sex-determining region Y) is expressed in the 
pre-Sertoli cells of the developing gonad between embryonic day e10.5 and e12 and 
activates SRY-box 9 (SOX9), which drives the differentiation of this cell type 
(Burgoyne et al., 1988). A critical threshold of SOX9-expressing Sertoli cells must be 
reached for male development to proceed as normal (Svingen and Koopman, 2013).  
1.1.3 Germ cells 
After the germ cells have colonised the gonads they arrest in mitosis. In females 
retinoic acid induces entry to meiosis, whereas in males retinoic acid is degraded 
preventing entry into meiosis (Bowles et al., 2006). In rodents primordial germ cells 
express octamer-binding transcription factor 4 (OCT4) and once they enter the 
gonad they begin to express mouse VASA homologue (MVH; (Toyooka et al., 2000). 
The gonocytes are highly proliferative until e13.5 when the rate slowly declines 
until a period of mitotic quiescence from e16 to just after birth (Vergouwen et al., 
1991, Nagano et al., 2000). OCT4 is then down-regulated in all germ cells between 
e17 and birth (Zayed et al., 2007).  
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 In humans during foetal life there is a heterogeneous population of germ cells with 
gonocytes and prespermatogonia present together (Anderson et al., 2007). The 
gonocytes, express pluripotency markers such as OCT4 (Gaskell et al., 2004) and the 
number of these cells progressively decline as they differentiate into pre-
spermatogonia expressing MVH and MAGE-A4 (melanoma-associated antigen 4; 
(Gaskell et al., 2004, Anderson et al., 2007). The OCT4+/MAGE-A4– gonocytes are 
highly proliferative, while the MAGE-A4+/OCT4– prespermatogonia have a lower 
proliferation rate (Mitchell et al., 2010).  
1.1.4 Sertoli cells 
The Sertoli cells role in foetal life is to direct masculinisation of the gonad (Sharpe et 
al., 2003). There are few major changes to the Sertoli cells during this time. They 
proliferate at a low level and express markers of immaturity such as anti-Müllerian 
hormone (AMH). 
1.1.5 Foetal Leydig cells 
The foetal Leydig cells (FLCs) produce testosterone throughout testicular 
development, which is vital for masculinisation of the foetus (Griswold and 
Behringer, 2009). FLC origin is not fully understood with potential sources being the 
mesonephros (Mayerhofer et al., 1996, Nishino et al., 2001) or the coelomic 
epithlium (Karl and Capel, 1998).  Recent evidence points to FLCs being derived 
from both of these locations (DeFalco et al., 2011). FLC differentiation is driven by 
signals from the Sertoli cells such as Desert hedgehog (Yao et al., 2002) and platelet-
derived growth factor-α (Brennan et al., 2003). In humans the FLCs proliferate and 
differentiate between 7–14 weeks until they are mature polygonal cells that fill the 
interstitial space (Svechnikov and Söder, 2008).  
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1.2 Postnatal testis development 
1.2.1 Germ cell development 
In rodents the prespermatogonia are located in the centre of the seminiferous 
tubules and are quiescent at birth. At approximately postnatal day (pnd) 3–5 the 
germ cells resume proliferation. Potential signals from the Sertoli cells to trigger this 
process include platelet derived growth factor and 17β-estradiol (Li et al., 1997). 
Coincident with this, the germ cells migrate to the basement membrane, where they 
enter the spermatogonial stem cell (SSC) niche (Payne, 2013). Cells that remain in 
the centre of the tubules and fail to migrate subsequently undergo apoptosis (Payne, 
2013). There is a dramatic increase in the number of SSCs within the testis between 
birth and adulthood (Shinohara et al., 2001). In the rodent the Asingle SSC acts as both 
the stem cell and the progenitor cell, whereas in humans the Adark is thought to be 
the true stem cell and Apale the proliferating progenitor that acts as a functional 
reserve (Fig. 1.2; (Jahnukainen et al., 2006). This results in different roles for the true 
stem cells between different species. These SSCs reside within a specific niche 
created by the Sertoli cells, basement membrane, and vasculature (Yoshida et al., 
2007). There are many factors implicated in the regulation of this niche including 
glial cell-derived neurotrophic factor (GDNF), colony stimulating factor 1 (CSF-1) 
and fibroblast growth factor 2 (FGF2; (Oatley and Brinster, 2012).   




Figure 1.2 SSCs in mouse and humans. As = A-single, Apr = A-paired, Aal = A-aligned. 
Adapted from (Jahnukainen et al., 2006). 
1.2.2 Sertoli cell maturation 
Sertoli cells must proliferate in neonatal life to produce final numbers before 
terminally differentiating around puberty.  This is vitally important, as each Sertoli 
cell can only support a defined number of germ cells and therefore any decrease in 
the final number of Sertoli cells will decrease the maximum germ cell producing 
capacity of the testis (Orth et al., 1988). In humans, this proliferation is thought to 
occur in two phases, one in the foetal and neonatal period, and the other at the onset 
of puberty (Murray et al., 2000). This is in contrast to rodents that do not have a 
‘childhood’ period and proliferation continues from foetal life until pnd17 
(Vergouwen et al., 1991). The proliferation of Sertoli cells is under the control of 
androgens and a knockout of the androgen receptor (AR) results in a decrease in the 
number of Sertoli cells at birth (Johnston et al., 2004). This is despite a lack of the AR 
in Sertoli cells during this period, and therefore must be an indirect effect through 
action of other cells in the testis (Sharpe, 2010). The Sertoli cells express different 
functional markers throughout life, such as AMH in the foetal and neonatal period. 
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As the Sertoli cells reach terminal differentiation the AR is expressed and AMH is 
lost (Sharpe et al., 2003). SOX9 is used as a marker for the Sertoli cells in this thesis 
as it is expressed in both the foetal and neonatal periods and is not affected by 
developmental stage. 
 
Figure 1.3 Proliferation and maturation of Sertoli cells in the rat and human 
testis. In the human testis there is an increase in proliferation in neonatal life followed by a 
quiescent period until puberty. In the rat there is no quiescent period as neonatal and 
prepubertal periods overlap. Adapted from (Sharpe et al., 2003). 
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1.2.3 Leydig cell development 
The differentiation of adult Leydig cells occurs at puberty from a stem cell 
population distinct from the FLCs (Fig. 1.4). The adult Leydig cell progenitors 
proliferate in neonatal life, and then at puberty express steroidogenic enzymes and 
cease proliferation. In humans the FLCs regress in the first year of life after 
contributing to the high testosterone levels in neonatal life (Svechnikov and Söder, 
2008). Upon stimulation with luteinizing hormone (LH) neonatal Leydig cells 
proliferate and begin to differentiate into the mature adult Leydig cells (Fig. 1.4; 
(Habert et al., 2001).  
 
 
Figure 1.4 Development of the foetal and adult Leydig cells. Early in neonatal life 
the FLCs degenerate and the neonatal Leydig cells begin to mature. The adult Leydig cells 
only reach maturity at puberty. Yellow dots indicate cytoplasmic lipid droplets Adapted 
from (Svechnikov and Söder, 2008). 
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Chicken ovalbumin upstream promoter transcription factor 2 (COUPTFII) is used 
extensively in this thesis as a marker of the interstitial cell population. COUPTFII is 
an orphan nuclear receptor, and ablation during prepuberty results in infertility, as 
Leydig cell differentiation is arrested (Qin et al., 2008). COUPTFII is present in the 
majority of interstitial cells in the neonatal testis, but is not found in the tubules. It 
marks a heterogeneous population of cells. It has been shown that cells that are 
COUPTFII+/3β-HSD- in the foetal testis are adult Leydig stem cells (ALSCs) and 
interference with  these cells can result in disturbed function of adult Leydig cells in 
later life (Kilcoyne et al., 2014).  
1.3 Spermatogenesis 
Spermatogenesis is the process by which spermatogonia differentiate into mature 
sperm, and begins at puberty. It is composed of three main phases: mitosis, meiosis 
and spermiogenesis (Fig 1.5). Initially the spermatogonia proliferate and 
differentiate into primary spermatocytes. These mitotic divisions determine the 
number of sperm produced, as proliferation stops and each spermatocyte undergoes 
meiosis to produce four haploid spermatids. Finally, the spermatids undergo the 
process of spermiogenesis, where they undergo morphological and functional 
maturation to produce mature spermatozoa. This process is spatially organised in 
the testis with the more mature stages situated closer to the lumen of the tubule. At 
this age the Sertoli cells form the blood—testis barrier comprised of tight junctions 
between adjacent Sertoli cells (Fig. 1.5). This barrier separates the proliferating 
spermatocytes in the basal compartment from meiosis and spermiogenesis, which 
occur in the adluminal space (Cheng and Mruk, 2002). Testosterone and follicle 
stimulating hormone (FSH) are both required for normal levels of spermatogenesis 
(O'Shaughnessy, 2014), as a double knockout of both the FSH receptors and AR 
specifically in the Sertoli cells showed a massive reduction in germ cell number and 
failure to enter meiosis (Abel et al., 2008). This was an additive effect over the single 
mutants (Abel et al., 2008).  




Figure 1.5 Spermatogenesis. The three stages of spermatogenesis are indicated along 
with the position of the blood—testis barrier separating the basal from the adluminal 
compartment. Adapted from (Cheng and Mruk, 2002). 
1.4 Childhood cancer 
In the UK there are approximately 1,600 children aged 0–14 diagnosed with cancer 
every year. This means 1 in every 500 children will develop a cancer by the age of 14 
(Cancer Research UK, 2014). Five-year survival rates have now reached 82% 
resulting in a large cohort of survivors of childhood cancer (Cancer Research UK, 
2014). Nearly one third of all childhood cancers are leukaemia, and the most 
common solid tumours are brain and spinal tumours (Stiller et al., 2012). Due to the 
variety of childhood cancers, treatment is also highly variable but is often a 
combination of surgery, chemotherapy and radiotherapy.  
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1.4.1 Fertility following chemotherapy 
Chemotherapy can cause a variety of adverse side effects in both the long and short 
term. Infertility can be of concern to both patients and parents of children treated for 
cancer. Chemotherapy primarily targets dividing cells and therefore the 
proliferative seminiferous epithelium is particularly vulnerable to chemotherapy-
induced damage.  The risk of infertility appears related to the specific drugs given 
(Meistrich et al., 1982) and the cumulative dose received, with alkylating agents 
thought to be the most gonadotoxic. 
 
The Childhood Cancer Survivor Study has provided long term outcome information 
from children who survived cancer in the 1970s and 80s, with a large cohort of over 
6,000 people (Green et al., 2010). This indicated that children exposed to 
procarbazine or cyclophosphamide (CYP) were less likely to sire a pregnancy than 
their siblings (Green et al., 2010). However, this study uses entirely self-reported 
questionnaire data with no semen or hormone analysis. The St. Jude Lifetime 
Cohort Study has a much smaller cohort but used semen analysis and indicated that 
25% of adult male survivors of childhood cancer had azoospermia with a further 
28% presenting with oligospermia (Green et al., 2014). Despite a trend for higher 
doses of alkylating agent to have an increased chance of impaired spermatogenesis, 
there was no clear threshold at which this occurred making it difficult to predict 
clinical outcomes (Green et al., 2014). Only at highest cumulative doses of CYP are 
men completely sterile (Jahnukainen et al., 2011), with incomplete depletion of the 
SSCs in boys treated for acute lymphoblastic leukaemia (Nurmio et al., 2009a). If 
even a few stem cells survive, they can restore fertility long term (Nurmio et al., 
2009a). Despite the effect on fertility, psychological assessment of survivors of 
childhood cancer indicates a similar quality of life between survivors and controls 
(Zeltzer et al., 2008, Gunn et al., 2013).  
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The Leydig cells re more resistant to chemotherapy than the seminiferous 
epithelium (Howell and Shalet, 2001) but, childhood cancer survivors can still suffer 
from hypogonadism, which can result in depression, disturbed metabolism and 
cardiovascular disease (Romerius et al., 2009).  
1.4.2 Fertility preservation and potential preventative treatments 
When adult men undergo gonadotoxic chemotherapy they have the option of 
cryopreserving a sperm sample prior to treatment, should they wish to have their 
own genetic children following treatment. This is not available for prepubertal 
patients, who do not yet produce mature sperm (Valli et al., 2014). A number of 
different experimental options for preservation are being investigated (Fig. 1.6) 
including using testis tissue for transplantation (Schlatt et al., 2003, Goossens et al., 
2008) or culture to mature sperm in vitro (Sato et al., 2011). Or the testis biopsy could 
be used for SSC enrichment and culture followed by transplantation (Sadri-
Ardekani et al., 2011, Hermann et al., 2012). A final potential treatment could be 
using induced pluripotent stem cells (iPSC) from skin biopsies for differentiation 
into sperm (Fig 1.6; (Hayashi et al., 2011, Easley et al., 2012). If sperm are produced 
in vitro they would need to undergo intracytoplasmic sperm injection (ICSI) in order 
to fertilise an oocyte.  
 
 





Figure 1.6 Fertility preservation in male patients. The only standard method for 
fertility preservation is storing sperm followed by assisted reproductive techniques. There 
are a number of experimental techniques in development. Testis tissue biopsies can provide 
tissue for transplantation, or culture and cells for culture followed by transplant or in vitro 
maturation. Skin biopsies could also be taken and iPSCs produced and differentiated into 
germ cells to be used for transplantation or ICSI. Adapted from (Clark et al., 2011). 
Because there are no fertility preservation options for prepubertal boys, efforts have 
been made to reduce the susceptibility of the testis to chemotherapy induced 
damage. A lot of research has been done into hormonal methods of preventing the 
proliferation of the germ cell population and therefore protecting it from cytoxotic 
agents that target dividing cells. In rats administration of steroid hormones or 
gonadotrophin releasing hormone protected the SSCs from procarbazine induced 
death (Parchuri et al., 1993).  However, in humans this has proved unsuccessful 
(Waxman et al., 1987, Thomson et al., 2002, Johnson et al., 1985).  
 




Three chemotherapeutic agents were investigated in this project. CYP was chosen, 
as it is believed to be the one of the most gonadotoxic and widely used 
chemotherapeutic agents. Cisplatin (CIS) and doxorubicin (DOX) were also tested, 
as both are used to treat prepubertal patients and represent two different classes of 
chemotherapeutics. They have been shown to have different effects on the ovary, 
with CIS primarily targeting the germ cells, and DOX affecting the supporting 
granulosa cells (Morgan et al., 2013).  
1.5.1 Cyclophosphamide 
CYP is an alkylating agent, one of the most successful anti-neoplastic agents 
developed, and has been used extensively in the treatment of cancer since the late 
1950s (Emadi et al., 2009).  It is a prodrug that has to be activated in the liver to 4-
hydroxycyclophosphamide (Fig.1.7). This then can transform into aldophosphamide 
which readily dissociates in cells to the active metabolite phosphoramide mustard 
(PM), producing acrolein as a by-product (Boddy and Yule, 2000).  PM causes DNA 
crosslinks at guanine residues, which prevent DNA replication (Dong et al., 1995). 
When this cannot be repaired, cells undergo apoptosis. Aldophosphamide can be 
inactivated by aldehyde dehydrogenase to carbophosphamide (Fig 1.7) and 
therefore cells with high levels of aldehydehydrogenase are resistant to CYP 
induced damage (Hilton, 1984).  
 





Figure 1.7 Activation of CYP. CYP is activated in the liver to 4-
hydroxycyclophosphamide where it transforms into aldophosphamide. This can then be 
activated  into the alkylating compound PM. In cells with a high level of ALDH 
aldophosphamide is inactivated to carboxyphosphamide. Adapted from (Emadi et al., 2009) 




CIS is a chemotherapeutic drug usually given to combat a variety of cancers 
including sarcomas, lymphomas and germ cell cancers. It has a platinum core with 
two amino groups and two chloride ions. When CIS enters a cell, the chloride ions 
become displaced by water. The resulting product is an electrophile and therefore 
able to bind to the nucleophiles within the cell, for example as DNA or proteins 
(Dasari and Tchounwou, 2014). CIS primarily binds to purine bases in DNA and 
forms intra-strand crosslinks (Wang and Lippard, 2005). These crosslinks produce a 
physical distortion in the DNA, triggering a whole cascade of downstream cellular 
effects. This damage will initiate repair mechanisms, such as the nucleoside excision 
repair, and mismatch repair systems (Gonzalez et al., 2001). However, when the 
damage is too great for the cell to repair, the apoptotic signalling pathways are 
activated.  
 
Recently increasing importance has been given to the non-nuclear effects of CIS, as 
it has been shown that CIS can induce apoptosis when the nucleus is removed from 
cells (Mandic et al., 2003), and that only 1% of cellular accumulated CIS is found 
bound to the DNA (Yu et al., 2008). Particular emphasis has focused on oxidative 
stress targeting the mitochondria of the cell.  CIS inhibits antioxidant enzymes and 
therefore reactive oxygen species can cause mitochondrial dysfunction and release 
pro-apoptotic factors leading to cell death (Sancho-Martinez et al., 2012). In 
addition, the endoplasmic reticulum (Mandic et al., 2003) and lysosomes (Sancho-
Martinez et al., 2012) have been implicated in the cytotoxicity of CIS. This indicates 
that there is a whole host of cellular targets for CIS. Once total cellular damage 
reaches a critical threshold the cell can no longer repair itself and the cell undergoes 
apoptosis.   
  




DOX is an anthracycline antibiotic that has been used in the treatment of cancer for 
over 50 years and is used in the treatment of solid tumours in childhood (Minotti et 
al., 2004). DOX has been proposed as having many different mechanisms of action 
such as inhibition of DNA synthesis (Wang et al., 1972), DNA intercalation 
(Cullinane et al., 1994), and the generation of free radicals resulting in oxidative 
stress (Bachur et al., 1977). However, the majority of work has been completed at 
concentrations greater than 1 µM (Gewirtz, 1999), even though 1–2 µM is the 
maximum initial concentration observed in patients’ serum and falls rapidly to 0.01–
0.1 µM (Greene et al., 1983).  The most likely mechanism of action is as a 
topoisomerase inhibitor, as cells that have a reduction in topoisomerase activity are 
resistant to DOX (Deffie et al., 1989). DOX primarily targets topoisomerase II, which 
unwinds DNA by transiently forming DNA double strand breaks. DOX stabilises 
the complex that forms between DNA and topoisomerase II following DNA 
cleavage, and therefore prevents replication and transcription by leaving double 
strand breaks unsealed (Tewey et al., 1984). However, it has been noted that there is 
little DNA damage to account for the degree of cell death, and therefore it has been 
suggested that the site of double strand breaks may be important and that DOX 
causes these at specific gene loci, resulting in irreversible damage (Capranico et al., 
1990). 
1.6 Aims of the thesis 
The aims of this project were to: 
 To examine the culture of postnatal mouse testis tissue for use in 
toxicological testing. 
 To examine the effect of CYP, CIS or DOX on the prepubertal mouse testis 
using an in vitro culture system. 
 To examine the culture of human foetal testis tissue and start investigation 
into the effect of chemotherapy on this tissue. 
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Chapter 2. General material and methods 
2.1 Animal work 
All experiments were approved by the University of Edinburgh ethical review 
committee and carried out in accordance with UK Home Office regulations. 
Animals had access to food and water ad libitum. C57Bl/J6 or CD1 mice were used 
for all experiments as indicated in subsequent chapters.  
2.1.1 Dissection 
Mice were killed by decapitation and the testes dissected into filter sterilised 
dissection media consisting of Leibowitz L-15 (Invitrogen, UK) solution 
supplemented with 3 mg ml-1 bovine serum albumin (BSA; Sigma Aldrich Ltd., UK), 
which had been warmed at 37 °C for at least 30 min prior to use. Whole control 
uncultured testes were washed in Dulbecco’s phosphate-buffered saline (DPBS; 
Invitrogen, UK) before being fixed as described below (see 2.4).  
2.1.2 Preparation of mouse testis tissue for culture 
Using insulin needles, the testes were cleaned up of any other tissue. Each testis was 
then dissected using an Altomed blade into 30 to 40 pieces approximately 0.5 mm3 
in the dissection media above (see 2.1.1) in preparation for addition to culture 
medium. 
2.2 Media composition 
2.2.1 Basic medium 
The basic medium was composed of α-minimal essential medium (α-MEM; 
Invitrogen, UK) supplemented with 10% knockout replacement serum (KRS; 
Invitrogen, UK). The medium was filter-sterilised and equilibrated at 37 °C and 
5% CO2 for at least 1 h before use.  
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2.2.2 Enriched medium 
An enriched medium was also prepared for some cultures. This consisted of α-MEM 
supplemented with 1 × MEM non-essential amino acids (Invitrogen, UK), 2 mM 
sodium pyruvate (Sigma-Aldrich, UK), 2 mM L-glutamine (Invitrogen, UK), 1 × ITS 
(insulin, transferrin and selenium; Sigma-Aldrich, UK), 1 × Penicillin-streptomycin 
(Invitrogen, UK) and 10% foetal calf serum (Biosera, UK). The medium was filter-
sterilised and equilibrated at 37 °C and 5% CO2 for at least 1 h before use.  
2.3 Chemotherapeutic agents 
2.3.1 Cisplatin 
Cis-Diammineplatinum(II) dichloride (Cisplatin; Sigma-Aldrich, UK, P4394-25MG) 
was dissolved in sterile water to prepare an aqueous solution of 1 mg ml-1. This was 
then serially diluted in sterile water into Eppendorf tubes to produce stock 
concentrations of 1 mg ml-1, 0.5 mg ml-1 and 0.1 mg ml-1. This was made up prior to 
culture and stored in the dark for up to 4 weeks. These stock solutions were then 
added to media to reach the appropriate dilution before addition to the culture.  
2.3.2 Doxorubicin 
Doxorubicin hydrochloride (Doxorubicin; Sigma-Aldrich, UK, D1515-10MG) was 
dissolved in sterile water to prepare an aqueous solution of 1 mg ml-1. This was then 
serially diluted in sterile water into Eppendorf tubes to produce stock 
concentrations of 0.5 mg ml-1. 0.1 mg ml-1 and 0.05 mg ml-1. This was made up prior 
to culture and stored in the dark for up to 4 weeks. These stock solutions were then 
added to media to reach the appropriate dilution before addition to the culture. 
2.3.3 Phosphoramide mustard 
PM (Niomech, Germany) was weighed out in a secured Eppendorf tube and media 
was added to bring the concentration to 0.1 M solution. This was then serially 
diluted in media to the appropriate concentrations to be added to the culture. PM is 
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highly volatile and therefore control cultures were performed in separate plates at a 
different level of the incubator to avoid contamination.  
2.4 Tissue fixation and processing 
Tissue was washed in DPBS before being placed in 10% neutral buffered formalin 
solution (NBF; Sigma-Aldrich, UK) for between 90 and 120 min to fix the tissue. 
Each piece of tissue was placed into microwave-melted 3% agar w/v (Sigma-
Aldrich, UK) before being processed and embedded in paraffin wax. The tissue was 
then sectioned at 5 µm on a microtome and floated out into a water bath heated to 
40 °C. Sections were mounted onto coated slides (Thermo Scientific, UK) and dried 
overnight.  
2.5 Haematoxylin and eosin (H&E) staining 
Sections were dewaxed in xylene for 2 × 5 min and rehydrated through decreasing 
concentrations of alcohols (100%, 95%, 90% and 70%) prior to being washed in 
water. Slides were then placed in haematoxylin solution for 3 min followed by 15 s 
in acid alcohol to differentiate and remove background staining. The slides were 
then placed in Scott’s Tap Water Substitute for 2 min to turn the haematoxylin blue 
to increase the contrast. Finally, the slides were placed in eosin for 3 min before 
being dehydrated in increasing concentrations of alcohol and cleared in xylene for 
5 min. Slides were mounted with DPX (distyrene, a plasticizer, and xylene).  
2.6 Immunofluorescence 
Slides were dewaxed and rehydrated as previously described for the H&E staining 
and washed in water.  
2.6.1 Antigen retrieval 
Antigen retrieval was performed, if required, as noted for individual antibodies 
(Table 2.1). Slides were placed in 0.01 M citrate buffer (pH 6, Sigma-Aldrich, UK) 
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and microwaved for 4 × 5 min. Between each set of 5 min the level of citrate buffer 
was checked and topped up with at most 50 ml of H2O to ensure that the slides did 
not dry out. The slides were then cooled for a minimum of 20 min before being 
washed in phosphate-buffered saline (PBS; Fisher Scientific, UK). 
2.6.2 Blocking 
Slides were blocked in 20% normal serum diluted in 1 × PBS + 0.1% Tritonx (PBSTx; 
Sigma-Aldrich, UK) and 5% w/v BSA (Sigma-Aldrich, UK) for 1 h at room 
temperature. The appropriate serum was used depending on the species in which 
the secondary antibody was raised.  
2.6.3 Primary antibodies 
The primary antibodies were appropriately diluted in blocking serum and 
incubated with the slides overnight at 4 °C in a humidified box. For double 
immunofluorescence both the primary antibodies were incubated together. One 
section was incubated with blocking serum alone to act as a negative control.  
Table 2.1 Primary antibodies and conditions used. 
Antibody Company Species Dilution Retrieval 
MVH Abcam Mouse 1:100 Yes 
CC3 Cell Signalling Technology Rabbit 1:500 Yes 
SOX9 EMD Millipore Rabbit 1:100 No 
BrdU Abcam Rat 1:500 Yes 
COUPTFII R&D Systems Mouse 1:200 Yes 
OCT4 Abcam Goat 1:200 Yes 
CC3: Cleaved Caspase-3; BrdU: 5-bromo-2’-deoxyuridine;  
2.6.4 Secondary Antibodies 
Slides were washed for 3 × 5 min in PBSTx before being incubated with an 
appropriate secondary antibody diluted 1:200 in blocking solution. Secondary 
antibodies were either a biotinylated secondary (Vector Laboratories, USA), to allow 
amplification before visualisation, or a direct fluorescent Alexa Fluor IgG1 
(Invitrogen, UK). Further details of this process are given in individual chapters. For 
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double immunofluorescence one of each type of secondary was used. For this and 
all subsequent steps slides were kept in the dark.  
2.6.5 Visualisation 
Following incubation with secondary antibody slides were again washed in PBSTx 
for 3 × 5 min. The visualisation reagent (streptavidin conjugated fluorescent labels; 
Invitrogen, UK) was added at 1:200 diluted in blocking solution for 30 min. This 
step was omitted for single immunofluorescence when a direct Alexa Fluor 
conjugated secondary antibody was used.  
2.6.6 Counterstaining and mounting 
Slides were washed for a further 2 × 5 min in PBSTx before being incubated with 
4’,6-diamidino-2-phenylindole (DAPI; Invitrogen, UK) diluted at 1:5000 for 10 min. 
Sections were then quickly washed in PBS before being mounted with hard-set 
VECTASHIELD (Vector Laboratories, USA) and kept in the dark at 4 °C until image 
acquisition.  
2.7 Image acquisition 
H&E images were taken with a DMLB Leica microscope integrated with a Leica 
DFC480 camera (Leica, UK). Fluorescent images were taken on Leica DM5500B 
microscope and captured with a DFC360X camera (Leica, UK).  
2.8 Image analysis 
All image analysis was performed using ImageJ. Section areas and tubule areas 
were calculated by manually selecting the section, or surrounding all of the tubules 
within an image with the selection tool, and measuring the area in pixels. For tubule 
diameters a line from one basement membrane to the opposing membrane was 
drawn and its length was measured. This was only done for complete tubules 
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within the image. When the tubules were not round, the shortest diameter was 
measured (Fig. 2.1). 
 
Figure 2.1 Calculation of tubule diameter. Tubule diameter (yellow lines) was 
calculated by drawing a line across the seminiferous tubules and measuring its length.  
In order to calculate the area of the immunofluorescent staining, the captured image 
was split into individual channels (greyscale representations of fluorophore colours 
making up the image; Fig. 2.2A). A threshold was then be selected, effectively 
filtering out the background of the image and leaving only the stained areas of 
interest (Fig. 2.2B). This threshold filter would then be used to convert the 
photograph into a binary image (Fig. 2.2C), with the background being ignored 
(binary 0 value) and the foreground staining the only present pixels (binary 1 
value). The area of staining could then be measured by selecting the converted 
image and using the inbuilt ImageJ pixel counting tool. A single threshold value 
was used for the analysis of all pieces within a single run of the immunofluorescent 
staining. If the selected threshold (Fig. 2.2C) resulted in a significant amount of 
image background not being filtered or if a lot of the staining of interest was 
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filtered, the threshold was adjusted to a more appropriate value for that specific 
image. Each cultured testis fragment or whole fixed testis was counted as n = 1.  
 
Figure 2.2 Analysis of fluorescent images. A) Single fluorophore image after channels 
had been split. B) A threshold is selected to separate staining (grey) from the image 
background (red). Finally C) the image is converted into a binary image where the 
background is discarded (white) and staining remains. This allows the selection of only the 
staining area and the calculation of area. 
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Chapter 3. Culture of postnatal mouse testis tissue 
3.1 Introduction 
Testicular organ culture is an in vitro technique that has been used in many different 
experimental settings. In comparison to cell cultures organ culture maintains the 
tissue architecture and the cell signalling required for normal testicular 
development. Organotypic testicular cultures date back to the 1920s and have been 
developed for foetal, postnatal and adult tissue in a variety of species.  
3.1.1 Membrane culture 
Culturing on a membrane has been the chosen method for culturing the neonatal 
mouse ovary in the lab. It sustains primordial follicle initiation and growth and has 
been utilised to examine the effects of chemotherapeutic agents (Morgan et al., 2013, 
Lopes et al., 2014). This technique has also been used to culture rat foetal and 
neonatal testis tissue (Habert et al., 1991, Hallmark et al., 2007, Li and Kim, 2003). It 
is thought to benefit the tissue as it is maintained at the interface between the 
medium and air allowing access to oxygen and medium. 
3.1.2 Culture on an agar block 
Culture on an agar block has been used extensively in embryonic gonad studies, 
mainly used for studying sex determination and testis formation (Martineau et al., 
1997, Combes et al., 2009). Culturing on agar block has also been established to 
investigate both hormonal and non-hormonal signalling in neonatal testicular 
development (Meehan et al., 2000, Zhou and Hutson, 1993). This method is believed 
to provide more structural support to the tissue and therefore is good for more 
delicate tissue. 
 
Using agar blocks for testicular culture was initially proposed for in vitro 
spermatogenesis in the 1950s, but was abandoned as there was no initiation of 
meiosis (Steinberger and Steinberger, 1970), and there has been increasing focus 
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placed on cell co-cultures rather than tissue culture. Recently, this technique has 
been further developed (Gohbara et al., 2010) and refined (Sato et al., 2011) to 
generate elongated haploid spermatids, which, when cultured for up to 60 days, 
could undergo ICSI and produce live offspring.  
3.1.3 Culture in hanging drops 
Hanging drops were originally developed for the culture of embryonic stem cells 
(ESCs). These form embryoid bodies via the aggregation of ESCs at the round 
bottom of the drop (Kurosawa, 2007). These embryoid bodies differentiate into 
committed cell types and have been used extensively as a tool to study the 
development of different tissues (Desbaillets et al., 2000).  
 
Culturing in hanging drops is a potential method for culturing testis tissue as it uses 
few resources and maintains the architecture of the tissue. This has been developed 
for mouse embryonic gonads and isolated adult seminiferous tubules (Szczepny et 
al., 2009), along with adult and foetal human testis tissue (Jorgensen et al., 2014, 
Jorgensen et al., 2015). In both of these reports, exogenous compounds were added 
to the cultures in order to manipulate specific signalling pathways. Therefore, 
hanging drop cultures could be a suitable model for testing the effect of exogenous 
agents on the testis.  
3.2 Aims 
The aims of this chapter were: 
 To compare the different methods of culturing the postnatal mouse testis in 
order to evaluate the appropriate methodology for subsequent work.  
 To compare the cultured testis tissue to testis development in vivo.  
 





Initial cultures on membranes or agar blocks were performed with CD1 mice, 
whereas hanging drops were performed separately with C57Bl/J6 mice. C57Bl/J6 
mice were used for the in vivo comparison experiments.  
3.3.2 Postnatal testis culture 
Following dissection (see 2.1.1 and 2.1.2) testes pieces were placed either basic 
media (see 2.2.1) or enriched media (see 2.2.2) and cultured in the following 
methods.  
3.3.2.1 Membrane 
A Millipore membrane (Camlab Ltd., UK) was placed on 1 ml of medium in a 24 
well plate (Greiner Bio-one, UK). A single piece of tissue was placed on each 
membrane using a sterilised, BSA coated glass pipette. After 48 h (Day 2) in culture 
0.5 ml of medium was removed from each well and replaced with fresh medium.  
3.3.2.2 Agar 
Small (10–20 mm) blocks of 2% agar (Sigma Aldrich Ltd., UK) diluted in PBS were 
prepared, sterilised and placed into 35 mm culture dishes. Medium was added to fill 
dish to the top of the block and left to equilibrate for 30 min to replace the PBS. 
Medium was then changed before the addition of three testis fragments to each agar 
block. Each day the level of medium was checked and topped up to the top of the 
agar block if required.  
3.3.2.3 Hanging drop 
25 µl of medium was placed on the lid of either a six well plate or a Petri dish with 
approximately 1 ml of DPBS placed in the bottom of the wells or dish to prevent 
evaporation. Each testis fragment was placed into the drop using a glass pipette and 
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then the lid inverted to allow the tissue to sink to the bottom of the drop. Testis 
fragments were transferred to a new plate with new drops of fresh medium after 48 
hours.  
 
After four days of culture using the methods outlined above, the tissue was fixed 
and processed (see 2.4). 
3.3.3 Haematoxylin & eosin staining  
H&E staining was performed as described (2.5). 
3.3.4 Immunofluorescence  
Immunofluorescence was performed as described (2.6) with antibody combinations 
as detailed in Table 3.1.  










































Gα-R Bio = Goat anti rabbit Biotinylated 
Gα-M Bio = Goat anti mouse Biotinylated 
Gα-M 568nm = Goat anti mouse IgG1 568nm 
Gα-R 488nm = Goat anti rabbit IgG1 488nm 
Strep = Streptavidin 
3.3.5 Image acquisition and analysis 
Images were acquired and analysed as described (2.7 and 2.8). 
Chapter 3 Culture of postnatal mouse testis tissue 
28 
 
3.3.6 Statistical analysis 
Statistical analysis was performed with GraphPad Prism. Analysis was based on at 
least five testis fragments or whole testes. The data were analysed with an analysis 
of variance (ANOVA) if the data followed a normal distribution, followed by 
Tukey’s post hoc test if the ANOVA was statistically significant to compare each 
group with each other. Where the data were not normally distributed a Kruskal-
Wallis test was performed followed by Dunn’s multiple comparison tests. All 
results are given as mean ±SEM with statistical significance set at p < 0.05. 
3.4 Results 
3.4.1 Neonatal mouse testis culture: membrane, agar, hanging drop  
3.4.1.1 General morphological analysis 
A general assessment of the culture techniques was made from H&E staining. The 
tubules were maintained when cultured by any of the methods with a clear 
flattened layer of PTMs surrounding the tubules (Fig. 3.1). The tissue cultured in 
hanging drops developed a spheroid shape, whereas cultures on a membrane or 
agar block flattened out. Some pyknotic cells were found in most of the sections 
examined; these were mainly toward the centre of the sections (Fig. 3.1).  




Figure 3.1 H&E culture of postnatal mouse testicular tissue by three methods. 
The general structure of cultures on membranes, agar or in hanging drops were compared. 
Scale bars = 100 μm. 
The area that the tubules occupied as a proportion of the section area tended to 
decrease in the hanging drop cultures (Fig. 3.2a) but this did not reach statistical 
significance (p = 0.078). The average tubule diameter was not affected by any of the 
culture techniques (Fig. 3.2b).  




Figure 3.2 Quantification of tubule properties in the cultured tissue. No 
significant differences were seen between culture techniques for A) the proportion of 
section that was tubules or B) the average tubule diameter. Bars represent mean ±SEM 
with n = 5 for membrane and hanging drop cultures and n = 6 for agar culture. p > 0.05. 
3.4.1.2 Germ cells and apoptosis in cultured testicular tissue 
In order to investigate whether the culture systems support germ cell development 
and the health of the tissue, sections were assessed with double 
immunofluorescence for MVH and CC3. MVH is expressed in all germ cells in the 
postnatal testis. CC3 is an effector caspase and part of the apoptotic pathway. Germ 
cells were supported with all culture techniques and there was little apoptosis in 
both the agar and membrane cultures. The hanging drops, however, showed high 
CC3 expression in the centre of each section (Fig. 3.3). 




Figure 3.3 Expression of MVH and CC3 in postnatal mouse testis cultured on a 
membrane, on agar or in a hanging drop. MVH (red) marked germ cells within the 
seminiferous tubules. There was little CC3 (green) except in the hanging drops. Sections 
were counterstained with DAPI (blue). Scale bars, red = 100 μm, white = 50 μm. 
The level of MVH was quantified and expressed relative to the area of the tubules in 
the section. This showed a trend towards a decrease in MVH expression in both the 
agar and hanging drop cultures relative to the membrane culture, but this was not 
significant (p = 0.17, Fig. 3.4).  




Figure 3.4 Quantification of germ cells in the mouse postnatal culture. Bars 
represent mean ±SEM with n = 5 for each technique. 
CC3 was quantified relative to the area of the section, as it was present in both the 
tubules and interstitium. There was little CC3 expression in the membrane and agar 
cultures but the hanging drops showed a much higher level of CC3 (Fig. 3.5).  
 
Figure 3.5 Quantification of apoptosis in the mouse postnatal culture. Data was 
not normally distributed and was analysed with Kruskal-Wallis test followed by Dunn’s 
multiple comparison test. Bars represent mean ±SEM with n = 5 for each technique, 
**p < 0.01. 
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3.4.2 Media comparison for hanging drop cultures 
Despite the hanging drops showing a high level of CC3 centrally this method has 
been examined in more detail. This is because it has been used previously to culture 
human foetal testis tissue. Therefore pnd5 testis fragments were cultured in hanging 
drops using either the basic medium used for all other techniques or an enriched 
medium developed for culturing human foetal testis. The enriched media showed 
no improvement over the basic media with both showing central cell death (Fig. 
3.6). In many cases the new media appeared worse with a larger area of pyknotic 
cells.  
 
Figure 3.6 Comparison of media for mouse postnatal hanging drop cultures. 
H&E stain of hanging drops cultured with a basic or enriched medium. Scale bars = 100 μm. 
3.4.3 Summary of method comparison 
When all results from the previous sections (see 3.4.1 and 3.4.2) were put together, 
this indicated that the hanging drops were not suitable for the culture of mouse 
postnatal testis tissue. There was no significant differences between the agar and 
membrane cultures. The agar culture is more labour and resource intensive and 
therefore all subsequent mouse cultures were performed on a membrane.  
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3.4.4 Cultured testicular tissue in comparison to in vivo time points 
3.4.4.1 General morphological analysis 
Testis fragments cultured for four days on a membrane were compared to two in 
vivo time points to assess whether the culture system supported testicular 
development. Pnd5 testis tissue was used as a pre-culture control and this was 
compared with pnd8 which assumes that culturing produces an approximately one 
day delay in development. There were few morphological differences observable 
from pnd5 to pnd8 in the mouse testis. The germ cells at pnd5 were very obvious, 
due to larger size and large volume of cytoplasm compared to the Sertoli cells. There 
was less difference between the two cell types by pnd8 (Fig. 3.7). It was hard to 
identify germ cells in the cultured tissue. The tubule diameter and the proportion of 
the section consisting of tubules increased from pnd5 to pnd8, but this was not 
observed in the cultured testis tissue (Fig. 3.8).  
 
Figure 3.7 H&E of postnatal testis tissue in comparison to cultured tissue. A) 
pnd5 B) pnd8 and C) cultured testis fragment. Arrows indicate germ cells. Scale 
bars = 50 μm. 
  




Figure 3.8 Quantification of tubule properties of postnatal mouse in comparison 
to cultured tissue. There was a statistically significant difference between A) the 
proportion of tubules per section and B) average tubule diameter. Bars represent mean 
±SEM with n = 5 for each group. *p < 0.05, **p < 0.01, ***p < 0.001. 
3.4.4.2 Seminiferous tubule composition  
The proportion of the tubule containing MVH-positive germ cells increased between 
pnd5 and pnd8 and there was a trend to this increase in the cultured tissue, 
although this did not reach significance (Fig. 3.9). There was little difference in the 
amount of SOX9 expression between the pnd5 and pnd8 testes. The control cultures 
had a reduced percentage of the tubules that were SOX9-positive (Fig. 3.10). 
COUPTFII marks the majority of the interstitial cells in the testis including the 
ALSCs. The proportion of the interstitium containing COUPTFII-positive cells did 
not change from pnd5 to pnd8 and this was maintained in the control cultured 
tissue (Fig. 3.11). 




Figure 3.9 Expression of MVH in the postnatal mouse testis. A) pnd5, B) pnd8 and 
C) control cultured testis. D) Quantification of MVH expression. Bars represent mean 
±SEM with n = 5 for each group. *p < 0.05 
 




Figure 3.10 Expression of SOX9 in the postnatal mouse testis. A) pnd5, B) pnd8 
and C) control cultured testis. Scale bars = 50 µm. D) Quantification of SOX9 expression. 
Bars represent mean ±SEM with n = 5 for each group. *p < 0.05 




Figure 3.11 Expression of COUPTFII and CC3 in the postnatal mouse testis.  
A) pnd5, B) pnd8 and C) control cultured testis. Scale bars = 50 µm. D) Quantification of 
COUPTFII expression. Bars represent mean ±SEM with n = 5 for each group. 
The cultured tissue had significantly more CC3 expression than the fixed testis 
tissue (Fig. 3.12). However, this was still a very small percentage of the total area 
and therefore was deemed an acceptable level of apoptosis.  




Figure 3.12 Quantification of CC3 expression in the postnatal mouse testis. 
There was an increase in CC3 expression in cultured testis p < 0.01. Bars represent mean 
±SEM with n = 5 for each group. **p < 0.01 
3.5 Discussion  
There appeared to be little difference between culturing on membrane and on agar 
blocks. The hanging drop cultures showed central apoptosis and this was not 
improved by using an enriched media. This was surprising as this protocol has been 
used successfully to culture human foetal tissue (Jorgensen et al., 2015). It would be 
interesting to test if this difference was due to species (mouse v human) or age of the 
tissue (embryonic v postnatal). To accomplish this embryonic mouse tissue of an 
equivalent age to human tissue could be cultured in hanging drops to see if this 
technique is better at supporting embryonic tissue.  
 
Successful murine hanging drops have only been reported over 48 hour culture, 
suggesting the four day culture is too long for this technique (Szczepny et al., 2009). 
These cultures were also using very small testes (e11.5) or isolated seminiferous 
tubules (Szczepny et al., 2009). The fragments presented here may have been too 
large to promote survival. Subsequent experiments using mouse postnatal testis 
tissue were cultured on membranes in the basic media due to lower labour and 
media requirements compared to the agar culture.  
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The culture on membrane was shown to support many of the characteristics of the 
neonatal mouse testis. As there are no major changes to the cell populations and 
structure of the testis over the time period examined from pnd5 to pnd8/9, the main 
function of the culture is to maintain the different cell types and structure. There 
was an increase in the ratio of total of tubule area to germ cell area, along with an 
increase in the diameter of the testis from pnd5 to pnd8. After birth the germ cells 
migrate from the centre of the tubules to the seminiferous epithelium where they 
resume proliferation (Jarvis et al., 2005) and therefore an increase in germ cell 
proportion during culture would be expected. The Sertoli cells should also be 
proliferating in the neonatal mouse testis, which occurs until approximately pnd17 
(Vergouwen et al., 1991). However, there was no increase in the proportion of 
tubules that were SOX9-positive between pnd5 and pnd8. This may be due to the 
higher proliferation rate in the germ cells, which would counteract the expected 
expansion in Sertoli cell number. The pieces of testis are not uniform in size or 
tubule composition, so quantification is given relative to tubule area and cannot 
detect absolute changes in number of cells. There were fewer Sertoli cells in the 
cultured tissue suggesting a loss of this cell type, but there were still a large number 
of these cells and they could still support the germ cell population. Unsurprisingly, 
the cultured tissue had substantially more cells undergo apoptosis than the fixed 
whole testes. However, the levels were still very low and appeared to have no effect 
on the testis structure.  
 
In conclusion, the membrane culture using a basic media appeared suitable for 
culturing mouse postnatal testis tissue for four days and retained the majority of 
features of postnatal testis development, although there are areas for improvement 
such as ensuring an increase in germ cell numbers and maintaining the correct 
number of Sertoli cells. This would ensure the tissue was more representative of 
normal development.  
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Chapter 4. The effect of cyclophosphamide, cisplatin 
and doxorubicin on the prepubertal testis 
4.1 Introduction 
4.1.1 Chemotherapy and infertility 
It was long believed that the testis was relatively protected from chemotherapy 
before puberty (Rivkees and Crawford, 1988). However, during prepubertal 
development there is germ cell division and Sertoli cell maturation, providing 
potential targets for chemotherapeutic drugs (Chemes, 2001), and children treated 
for cancer often suffer from infertility in adult life (Wallace et al., 2005). In order to 
develop preventative treatments, detailed information on how the testis is damaged 
and whether specific drugs cause injury through the same or different processes is 
required. There have been a number of studies examining the effect of different 
chemotherapy on the testis in rodents and these are discussed below for the three 
chemotherapeutic agents used in this chapter.  
4.1.2 Cyclophosphamide 
CYP is believed to be one of the most gonadotoxic anticancer agents. Exposure of 
adult male rats to CYP results in an increase in apoptosis of the germ cells (Cai et al., 
1997). However, even after multiple doses, fertility recovered, with the majority of 
cell death occurring in the differentiating germ cells and the undifferentiated 
spermatogonia relatively protected (Drumond et al., 2011). As CYP must be 
activated in the liver the metabolite, PM has been used here to examine the effect of 
CYP on the prepubertal testis. There is currently no information on the direct effect 
of this metabolite on the testis.  
  




Studies in adult mice show damage to the seminiferous epithelium and increased 
apoptosis of germ cells (Köpf-Maier, 1992, Zhang et al., 2001, Seaman et al., 2003). It 
is the dividing spermatogonia that are most susceptible to CIS, suggesting that the 
loss of fertility may be reversible, as the stem cells survive (Huang et al., 1990). 
However, chemotherapeutic agents are given to patients in multiple cycles and 
therefore the response to an initial exposure may affect the level of damage caused 
by later exposures. A multi-cycle exposure model was developed (Sawhney et al., 
2005) and it showed increased proliferation following exposure to CIS (Harman and 
Richburg, 2014). This made the testis even more susceptible to CIS induced damage 
on the second exposure, potentially targeting the SSCs, leading to irreversible 
azoospermia (Harman and Richburg, 2014). 
4.1.4 Doxorubicin 
DOX is considered to be the least gonadotoxic of the agents examined here. 
However, mice exposed to DOX prepuberty experienced apoptosis of germ cells 
(Brilhante et al., 2011), and it has been shown that the initiation of spermatogenesis 
may be particularly vulnerable (Hou et al., 2005). There is evidence of functional 
damage to Sertoli cells, but this was secondary to germ cell loss (Brilhante et al., 
2012). One in vitro investigation of DOX induced testicular damage using an organ 
culture of pnd5 testis (Nurmio et al., 2009b), similar to that developed here. This 
showed a loss of germ cells without effect on the Sertoli cell population. However, 
only a very short time window could be examined due to control tissue showing 
high levels of cell death and loss of tissue integrity (Nurmio et al., 2009b).  
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4.1.5 Summary of previous studies 
In all the studies above the primary mechanism of damage to the testis was through 
loss of germ cells. The studies mentioned above for CYP and CIS were performed 
using adult mice or rats. It cannot be assumed that these are applicable to the 
prepubertal testis, which has a different pattern of germ and somatic cell division. 
Therefore, it is important to examine the effect of chemotherapy before puberty.  
The in vitro model used here also means the direct effect of the drugs can be 
examined, the amount of chemotherapy reaching the testis is controlled, and young 
mice are not exposed to toxic chemotherapy drugs. 
4.1.6 Aims 
 The aims of the chapter were: 
 To examine the effect of three chemotherapeutic agents; CYP, CIS and DOX 
on the cell populations of the prepubertal mouse testis using an in vitro 
culture system. 
 To examine whether proliferation or apoptosis is affected by exposure to 
CYP, CIS or DOX.  
4.2 Methods 
4.2.1 Culture of postnatal mouse testis tissue 
A minimum of two pnd5 C57Bl/J6 mouse testes per culture were dissected (see 2.1.1 
and 2.1.2). Each piece was transferred into a 24 well plate, on a Whatman 
Nucleopore membrane floating on 1 ml of basic medium (see 2.2.1) and left for 24 h 
(Day 1). On Day 2 of culture, medium was supplemented with CIS, DOX or PM, 
each prepared as described (see 2.3). Media were replaced half in—half out to 
produce final concentrations (Table 4.1). Four doses of PM were selected due to the 
wide range of reported serum levels in patients (Tasso et al., 1992, Struck et al., 
1987). On Day 3, membranes were transferred into fresh control medium. For the 
final  
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day in culture (Day 4), medium was additionally supplemented with 15 µg ml-1 
5-bromo-2’-deoxyuridine (BrdU; Sigma Aldrich Ltd, UK). After 24 h, tissue was 
fixed and processed as described (see 2.4). For each chemotherapeutic agent a 
minimum of 7 testis fragments from each concentration were examined. These 
fragments came from a minimum of 3 cultures, except for 1 µg ml-1 PM where 
fragments were taken from 2 cultures only. 
Table 4.1 Final concentrations of chemotherapeutic agents 
Concentration PM CIS DOX 




0.5 µg ml-1 0.1 µg ml-1 
High 10 µM 1 µg ml-1 0.5 µg ml-1 
 
4.2.2 Haematoxylin and eosin staining 
H&E staining was performed as described (see 2.5).  
4.2.3 Immunohistochemistry 
Immunohistochemistry was performed as described (see 2.6) with the antibody 
combinations as detailed in Table 4.2.  


























































Gα-rat Bio = Goat anti rat Biotinylated 
Gα-rat 568nm = Goat anti ratIgG1 568n 
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4.2.4 Image acquisition and analysis 
Images were acquired and analysed as described (see 2.7 and 2.8). 
4.2.5 Statistical analysis 
Data were analysed using GraphPad Prism. To determine statistical significance 
between control and different concentrations of each drug, one-way ANOVA was 
performed followed by a Dunnet’s post hoc test, if the ANOVA was significant. 
Where the data were not normally distributed a Kruskal-Wallis test was performed 
followed by Dunn’s multiple comparison tests. All results are given as mean ±SEM 
with statistical significance set at p < 0.05. 
4.3 Results 
Firstly, the effect of PM on the neonatal mouse testis was examined as CYP is 
thought to be one of the most gonadotoxic chemotherapeutic agents and therefore it 
was used to test if the in vitro system was able to produce the same results in vivo. 
Next two other drugs, CIS and DOX were examined. These show differing effects in 
the ovary with CIS targeting the germ cells and DOX primarily targeting the 
supporting granulosa cells (Morgan et al., 2013).  
4.3.1 Phosphoramide mustard 
4.3.1.1 Depletion of germ cells at the highest doses of phsophoramide mustard 
In the control testis, MVH-positive germ cells were situated predominantly along 
the basement membrane of the seminiferous tubules and the majority were BrdU-
positive (Fig. 4.1A).  In response to exposure to PM there was a loss of the germ cells 
from the seminiferous tubules in a concentration dependent manner (Fig. 4.1B–E). 
At the two highest doses of PM there was a significant decrease in the proportion of 
germ cell area to tubule area, with none observed at the highest dose (Fig. 4.1F).  




Figure 4.1 Germ cells and proliferation on exposure to PM.  
A-E) Immunohistochemical localisation of MVH (red), BrdU (green), counterstained with 
DAPI (blue) for A) control cultured testis and fragments exposed to B) 0.01 µM, C) 0.1 µM, 
D) 1 µM, and E) 10 µM PM. White arrows indicate germ cells that are also BrdU-positive. 
Yellow arrows indicate germ cells without BrdU. Scale bars = 50 µm. F) The percentage of 
tubule area containing MVH-positive germ cells was quantified with n = 8 for each 
concentration. One-way ANOVA followed by Dunnet’s post hoc tests were applied. Data 
are mean ±SEM. *p < 0.01, ***p < 0.001 for each concentration of PM versus control. 
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4.3.1.2 Lack of effect of phosphoramide mustard on somatic cells 
The somatic cells, Sertoli and interstitial cells, were examined to see if they were 
affected by PM. The SOX9-positive Sertoli cells were found lining the seminiferous 
tubules in the control and some of these cells were proliferating, which is expected 
in early postnatal life (Fig. 4.2A). Even at the highest dose of PM, Sertoli cells were 
still present throughout the tubules and were dividing (Fig. 4.2B-E). There was no 
significant effect on the proportion of the tubule area occupied by Sertoli cells on 
exposure to PM (p = 0.38; Fig. 4.2F).  
 
Interstitial cells were examined by determining expression of COUPTFII, which is 
expressed in the majority of the interstitial cells in the neonatal mouse. It also labels 
the ALSCs that will differentiate in later life (Kilcoyne et al., 2014). The interstitium 
contained mainly COUPTFII-positive cells both in the control cultured testis and at 
the every concentration of PM (Fig. 4.3A-E). There was a trend towards an increase 
in the percentage of the interstitial area that contained COUPTFII-positive 
interstitial cells on exposure to PM, but this did not reach significance (p = 0.07; Fig. 
4.3F).  
 




Figure 4.2 Sertoli cells on exposure to PM. A-E) Immunohistochemical localisation of 
SOX9 (green), BrdU (green), counterstained with DAPI (blue) for A) control cultured testis 
and fragments exposed to B) 0.01 µM, C) 0.1 µM, D) 1 µM, and E) 10 µM PM. Scale 
bars = 50 µm. F) The percentage of tubule area containing SOX9-positive cells was 
quantified with n = 9 for the control tissue, n = 8 for 0.01  µM and 1 µM, and n = 7 for 
0.1  µM and 10 µM. One way ANOVA was applied but was not significant. Data are mean 
±SEM. 
 




Figure 4.3 Interstitial cells and apoptosis on exposure to PM.  
A-E) Immunohistochemical localisation of COUPTFII (red), CC3 (green), counterstained 
with DAPI (blue) for A) control cultured testis and fragments exposed to B) 0.01 µM, C) 
0.1 µM, D) 1 µM, and E) 10 µM PM. Scale bars = 50 µm. F) The percentage of the interstitial 
area containing COUPTFII-positive cells was quantified with n = 8 for each concentration, 
except 10 μM where n = 7. One-way ANOVA was applied but did not reach statistical 
significance. Data are mean ±SEM.  
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4.3.1.3 Lack of effect of phosphoramide mustard on proliferation 
BrdU was added to the culture for the final 24 h, in order to examine the 
proliferative capacity of the tissue following exposure to PM. There was no effect on 
the percentage of the section area that was BrdU-positive at any concentration of 
PM (p = 0.43; Fig. 4.4A). In the controls approximately 70% of the proliferation 
occurred in the tubules. This decreased to 50% in the exposed tissue, however, the 
decrease did not reach significance (p = 0.10; Fig. 4.4B).  
 
Figure 4.4 Quantification of proliferation on exposure to PM. A) The percentage of 
the testis fragment area that was BrdU-positive was quantified for each concentration of 
PM. B) The proportion of total BrdU that was found within the tubules with n = 8 testis 
fragments from each concentration. One-way ANOVA were applied but did not reach 
significance. Data are mean ±SEM.  
4.3.1.5 Increase in apoptosis at the highest dose of phosphoramide mustard 
Apoptosis was examined by carrying out immunohistochemistry for CC3. There 
was very little CC3 at the end of culture in both control and exposed sections (Fig. 
4.3A–E). The majority of CC3 was found in the interstitium (Fig. 4.5A). This was 
unexpected as CC3 would be anticipated to be high in the tubules due to the specific 
loss of germ cells. Despite this, CC3 expression increased threefold at the highest 
dose of PM in comparison to control cultured testis (Fig. 4.5B). This pattern was 
replicated when CC3 was just examined within the tubules (Fig. 4.5C), except at 
0.1 µM, where a single piece showing very high levels of CC3 skewed results 
somewhat.  




Figure 4.5 Quantification of apoptosis on exposure to PM. A) The proportion of 
CC3 in each testis compartment, tubules or interstitium was quantified for each 
concentration of PM along with the percentage of B) total section area or C) tubule area 
that is CC3-positive for each concentration. n = 8 for each concentration, except 10 μM 
where n = 7.The level of CC3 was not normally distributed and therefore a Kruskal-Wallis 
test was applied followed by Dunn’s post hoc test. Data are mean ±SEM. *p < 0.05, 
**p < 0.01 for PM versus control. 
4.3.2 Cisplatin and doxorubicin 
4.3.2.1 Structure of testis following exposure to cisplatin or doxorubicin 
Examination of H&E sections showed that both the control tissue and samples 
exposed to CIS or DOX had morphologically normal tubules with basement 
membrane separating the tubules from the interstitium. At the lowest dose of CIS or 
DOX a few germ cells could be observed either at the basement membrane or in the 
centre of the tubules (Fig. 4.6). At the high dose of CIS or DOX germ cells could not 
be identified and there were many pyknotic cells. As the concentration of CIS or 
DOX increased there was a reduction in the tubule area to section area ratio and a 
reduction in the tubule diameter (Fig. 4.7) 




Figure 4.6 H&E of postnatal mouse testis tissue on exposure to CIS or DOX.  
A) Control cultured testis and fragments exposed to B) CIS or C) DOX at the (i) lowest 
and (ii) highest concentration. Main image scale bars = 50 µm, inset scale bars = 20 μm.  
 




Figure 4.7 Quantification of tubule properties on exposure to CIS or DOX. 
Quantification of A) proportion of tubule area to section area, and B) tubule diameter with 
n = 8 for each concentration of (i) CIS or (ii) DOX. One-way ANOVA followed by 
Dunnet’s post hoc tests were applied. Data are mean ±SEM. *p < 0.05, **p < 0.01, 
***p < 0.001 for CIS or DOX versus control. 
4.3.2.2 Loss of germ cells following exposure to cisplatin or doxorubicin 
In the control cultures the majority of germ cells were BrdU-positive (Fig. 4.8A).  In 
response to exposure to CIS or DOX there was a significant loss of germ cells from 
the seminiferous tubules (Fig. 4.8B, Fig. 4.8C); this occurred at even the lowest 
concentrations of CIS or DOX (Fig. 4.8Bi, Fig. 4.8Ci). However, even at the highest 
dose of CIS or DOX there were examples of germ cells that had survived exposure. 
Some of these remaining germ cells were BrdU-positive (Fig 4.8Bii).  
 




Figure 4.8 Germ cells and proliferation on exposure to CIS or DOX.  
A-C) Immunohistochemical localisation of MVH (red), BrdU (green), counterstained with 
DAPI (blue) for A) control cultured testis and fragments exposed to B) CIS and C) DOX at 
the (i) lowest and (ii) highest concentration. White arrows indicate germ cells that are also 
BrdU-positive. Yellow arrows indicate germ cells without BrdU. White scale bars = 50 µm, 
yellow scale bars = 10 µm. The percentage of tubule containing MVH-positive germ cells for 
D) CIS or E) DOX was quantified with n = 8 for each concentration. One-way ANOVA 
followed by Dunnet’s post hoc tests were applied. Data are mean ±SEM. ***p < 0.001 for 
CIS or DOX versus control. 
Chapter 4 The effect of CYP, CIS and DOX on the prepubertal testis 
55 
 
4.3.2.3 Lack of effect of cisplatin or doxorubicin on somatic cells  
Somatic cells were examined to see if they were affected by CIS or DOX. In contrast 
to the loss of germ cells, on exposure to the highest concentration of CIS and DOX 
the Sertoli cells were still present throughout the tubules and were dividing (Fig. 
4.9). There was no significant effect on the proportion of the tubule area occupied by 
Sertoli cells on exposure to either CIS (p = 0.11), or DOX (p = 0.45; Fig. 4.9D–E).  
 
The interstitium contained mainly COUPTFII-positive cells in the control cultured 
testis and at the highest concentration of CIS and DOX (Figure 4.10A–C) There was 
no effect of drug on the percentage of the interstitial area that contained COUPTFII-
positive interstitial cells on exposure to CIS (p = 0.86), or DOX (p = 0.34; Fig. 4.10D–
E).  
 




Figure 4.9 Sertoli cells on exposure to CIS or DOX. A-C) Immunohistochemical 
localisation of SOX9 (green), BrdU (green), counterstained with DAPI (blue) for A) control 
cultured testis, and fragments exposed to the highest concentration of B) CIS and C) DOX. 
White arrows indicate cells co-staining for SOX9 and BrdU. Main image scale bars = 50 µm, 
yellow scale bars in insets = 10 µm. The percentage of tubule area containing SOX9-positive 
cells for D) CIS or E) DOX was quantified with n = 8 for each concentration. One-way 
ANOVA were applied but were not significant. Data are mean ±SEM.  
 




Figure 4.10 Interstitial cells and apoptosis on exposure to CIS or DOX.  
A-C) Immunohistochemical localisation of COUPTFII (red), CC3 (green), counterstained 
with DAPI (blue) for A) control cultured testis, and fragments exposed to the highest 
concentration of B) CIS or C) DOX. Scale bars = 50 µm. The percentage of the interstitial 
area containing COUPTFII-positive cells for D) CIS or E) DOX was quantified with n = 8 
for each concentration. One-way ANOVA were applied but were not significant. Data are 
mean ±SEM.  
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4.3.2.4 Decrease in proliferation following exposure to cisplatin or doxorubicin 
Proliferation was examined following BrdU administration for the final 24 h of 
culture. The total amount of BrdU significantly decreased at all concentrations of 
CIS or DOX (Fig. 4.11A). When this proliferation was investigated separately for the 
tubule and interstitial areas, a significant decrease in the percentage of the tubule 
area that was BrdU-positive was observed at all concentrations of CIS or DOX (Fig. 
4.11B). There was a trend towards a decrease in proliferation in the interstitium, but 
this only reached significance at the highest dose of DOX (Fig. 4.11C). In the control 
cultured testis, the majority of BrdU was found within the tubules (Fig. 4.11D), but 
this decreased at all concentrations on exposure to CIS or DOX, reflecting the loss of 
dividing germ cells.  
4.3.2.5 Increase in apoptosis following exposure to cisplatin or doxorubicin 
There was very little CC3 at the end of culture in all sections (Fig. 4.10A–C). The 
majority was found in the interstitium (Fig. 4.12A), rather than in the tubules, as 
would have been expected due to the specific loss of germ cells. Despite this, CC3 
expression increased 3.5- and 5.2-fold at the highest dose of CIS and DOX 
respectively, in comparison to control cultured testis (Fig. 4.12B). This pattern was 
replicated when CC3 was examined just within the tubules (Fig. 4.12C; 5.2- and 6.5-
fold increase).   
 




Figure 4.11 Quantification of proliferation on exposure to CIS or DOX. A) The 
percentage of the testis that was BrdU-positive was quantified for each concentration of (i) 
CIS or (ii) DOX. This was split into B) percentage of tubule area that was BrdU-positive, 
and C) percentage of the interstitium area that was BrdU-positive. D) The proportion of 
total BrdU that was found within the tubules with n = 8 for each concentration. One-way 
ANOVA followed by Dunnet’s post hoc tests were applied. Data are mean ±SEM. *p < 0.05, 
**p < 0.01, ***p < 0.001 for CIS or DOX versus control. 




Figure 4.12 Quantification of apoptosis on exposure to CIS or DOX. A) The 
proportion of CC3 in each testis compartment, tubules or interstitium was quantified along 
with the percentage of B) total section area or C) tubule area that is CC3-positive for each 
concentration of (i) CIS or (ii) DOX with n = 8 testis fragments from each concentration. 
One-way ANOVA followed by Dunnet’s post hoc tests were applied. Data are mean ± SEM 
**p < 0.01, ***p < 0.001 for CIS or DOX versus control.  
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4.3.2.6 Effect of cisplatin or doxorubicin after only 24 hours in exposure 
As all of the germ cells were depleted by the end of the 4 day culture protocol at all 
concentrations of CIS or DOX, some tissue was fixed 24 h after the addition of each 
of the chemotherapeutic agents, rather than transferring into fresh media. The 
control tissue that had not been exposed to either chemotherapeutic agent showed 
many MVH-positive germ cells and little apoptosis in both the tubules and 
interstitium (Fig. 4.13A). At the lowest dose of either CIS or DOX there appeared to 
be fewer germ cells (Fig. 4.13Bi, Fig. 4.13Ci), and at the highest dose of CIS there was 
a reduced number of germ cells, but with many still surviving (Fig. 4.13Bii). At the 
highest dose of DOX nearly all the germ cells had already been depleted and there 
was a very high level of CC3 expression (Fig. 4.13Cii). 
 




Figure 4.13 Germ call and apoptosis after 24 hours exposure to CIS or DOX. 
Immunohistochemical localisation of MVH (red) and CC3 (green), counterstained with 
DAPI (blue). A) Control cultured testis and fragments exposed to B) CIS or C) DOX and 
fixed after 24 hours exposure at the (i) lowest and (ii) highest concentration. Images are 
representative of a single culture with only one or two cultured fragments per 
concentration. Scale bars = 100 µm.  
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4.4 Discussion  
The results show a loss of germ cells when postnatal mouse testes were exposed to 
PM, CIS or DOX. The doses used here were chosen to be within the range of 
patients’ serum which is 0.1–10 µM PM (Tasso et al., 1992, Struck et al., 1987), 0.4–
1 µg ml-1 CIS (Urien and Lokiec, 2004, Crom et al., 1981) and 0.01–0.6 µg ml-1 DOX 
(Greene et al., 1983, Gewirtz, 1999). As most chemotherapy drugs primarily target 
dividing cells, the loss of germ cells is expected, as these are proliferating in the 
neonatal testis. This also fits with previous studies on rodents exposed to CYP, CIS 
or DOX, which show primarily a loss of the germ cells from the testis. However, 
even when the majority of germ cells were depleted there were a number that 
survived, and these were often dividing. If any of these cells were SSCs then over a 
long time period these could re-colonise the seminiferous tubules and contribute to 
recovery of fertility. Of all the germ cells, it would be expected that the stem cells 
would survive as they have a slower cell cycle. It has also been shown that in adult 
mice the differentiating spermatongonia are the most sensitive to chemotherapy 
induced damage and that the stem population is relatively protected (Drumond et 
al., 2011).   
 
All three chemotherapeutic agents had no effect on the number of Sertoli cells and 
interstitial cells. This supports previous studies indicating Sertoli cell number was 
not altered on exposure to CIS (Sawhney et al., 2005). However, it has been 
suggested that other properties may be altered, such as Sertoli cell shape and 
connections between cells (Köpf-Maier, 1992). Therefore Sertoli cell function and 
maturation is worth investigating. Over the course of neonatal development the 
Sertoli cells change from actively proliferating immature Sertoli cells expressing 
markers such as AMH, to the more mature quiescent cells expressing the AR 
(Sharpe et al., 2003). These markers could be examined to see if the Sertoli cells are 
maturing correctly or if maturation was altered by exposure to any of the 
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chemotherapeutic agents. Sertoli cells are vital for forming the SSC niche by 
secreting a wide variety of signalling molecules. One of the most important is 
GDNF (Oatley and Brinster, 2012). GDNF increased following exposure to multiple 
cycles of CIS (Harman and Richburg, 2014) and it would therefore be interesting to 
see if this was affected by CIS, DOX or PM.  
 
BrdU was added to the media for all of the final 24 h of culture and therefore marks 
all proliferation during this period. Proliferation was significantly decreased 
following exposure to all concentrations of CIS or DOX, but not in sections exposed 
to PM. This was surprising as at the highest dose of PM there was a loss of the germ 
cells, which are dividing in the control tissue. Therefore, with this population being 
lost, it would be expected the total proliferation would decrease. The fact there is no 
decrease would suggest that the surviving cells have increased proliferation. At the 
highest dose of DOX there was also a decrease in proliferation in the interstitium 
with very few cells dividing. This could indicate effects beyond the loss of germ 
cells. There was a downward trend, but not a significant decrease, in the number of 
COUPTFII-positive cells in the interstitium. If the ALSCs were lost then this could 
result in hypogonadism in later life.  
 
There was little apoptosis in both control and treated sections, however, when CYP 
is given to adult rats, apoptosis returns to control levels after 48 h (Cai et al., 1997) 
and therefore the wave of apoptosis may have been missed. The cell death was not 
confined to the tubules with the majority located within the interstitium by the end 
of the 4 day culture. This indicates that there are changes to the interstitium 
following exposure to chemotherapeutic agents, even if this could not be detected 
by the total expression of COUPTFII in the interstitium, which was not significant in 
any of the three chemotherapeutic agents. Other, more specific markers of different 
interstitial cell types such as 3β-HSD for Leydig cells, smooth muscle actin for the 
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PTMs and endothelial cells could be examined along with testosterone production 
by the cultured tissue, to be able to get a more complete picture of any damage to 
the interstitium.  
 
After 24 h the two drugs appeared to have different effects with a large amount of 
apoptosis at the high concentration of DOX with almost complete depletion of the 
germ cells. Conversely in the CIS treated tissue there was still many germ cells 
remaining. These must have been destined to die in the next 48 h as at the end of the 
4 day culture there were very few germ cells remaining. This may indicate that the 
different drugs have different mechanisms of action or that the time taken to initiate 
the same mechanism may vary between drugs. The initial damage could be 
investigated by carrying out a time course analysis and this is discussed further in 
6.2.2. At the concentrations studied here all three chemotherapeutics had similar 
actions. It was surprising that they all acted the same, as they are believed to have 
different gonadal toxicities, with CYP being associated with permanent 
azoospermia and CIS and DOX reversible azoospermia (Meistrich, 2013). In fact, at 
the doses used here CIS and DOX appeared more gonadotoxic. Doses were based 
on patients’ serum level, which is highly variable both between patients and 
between studies. The three drugs may have a different distribution throughout the 
body and therefore different concentrations to the ones presented here may reach 
the testis in clinical practice. More information is required on the levels of 
chemotherapeutics in the testis in children treated for cancer to inform scientific 
studies.  
 
All three chemotherapy drugs were all given as a single chemotherapeutic agent, 
whereas in clinical practice patients are not exposed to a single drug but a 
combination of many drugs, which may have additive or synergistic effects.   
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In conclusion, all three chemotherapeutic drugs examined here appeared to have 
very similar effects on the testis causing a specific loss of germ cells without effect 
on the somatic cells.  
 
Chapter 5 Human foetal testis culture 
67 
 
Chapter 5. Human foetal testis culture 
5.1 Introduction  
5.1.1 Culture of human testis tissue 
Efforts to culture human testicular tissue date back to the mid-20th century, when it 
was first proposed as a method for in vitro spermatogenesis (Steinberger, 1975).  
Adult human testis cultures have mainly focused on the ability of the tissue to enter 
meiosis and proved unsuccessful (Roulet et al., 2006). Subsequently, testis culture 
has been utilised to study the effects of exogenous agents such as phthalates 
(Desdoits-Lethimonier et al., 2012) and analgesics (Albert et al., 2013) on the testis.  
 
The culture of human foetal testis has been used to examine the effects of a wide 
variety of compounds (Habert et al., 2014). Results appear mixed, with some 
reporting preservation of tissue after four days in culture (Lambrot et al., 2006), and 
others showing central necrosis after only 48 h (Hallmark et al., 2007).  Hanging 
drop cultures have been used to culture adult testis tissue for up to 14 days 
(Jorgensen et al., 2014), and has recently been extended to human foetal tissue 
(Jorgensen et al., 2015). Work in this chapter has used this technique to examine the 
effects of chemotherapy on the human testis. 
5.1.2 Germ cells in the human foetal testis 
During foetal life the seminiferous cords form, Sertoli cells proliferate, and germ 
cells undergo differentiation. In the first trimester the majority of germ cells are 
gonocytes, which express pluripotency markers such as OCT4 (Gaskell et al., 2004, 
Rajpert‐De Meyts et al., 2004). Gonocytes then differentiate into prespermatogonia 
that express germ cell-specific markers such as MAGE-A4, VASA and DAZL 
(Gaskell et al., 2004, Anderson et al., 2007). In humans this is a gradual switch from 
gonocyte to spermatogonia from late first trimester to early postnatal life resulting 
in a heterogeneous population of germ cells (Mitchell et al., 2008), whereas in 
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rodents this occurs in a much narrow time window in all germ cells between e15.5 
and e19.5 in the rat (Ferrara et al., 2006) and between e17 and birth in the mouse 
(Zayed et al., 2007). Some OCT4-positive gonocytes are even present in the infantile 
human testis (Rajpert‐De Meyts et al., 2004). This heterogeneity means multiple 
markers must be used to visualise the germ cell population of the human testis.  
5.2 Aims 
The aims of this chapter were:  
 To examine the culture of human foetal testis tissue.  
 To start preliminary investigation into the effects of DOX or CIS on the 
human testis. 
Only two samples were available for this project at different stages of development 
and therefore no quantification was attempted in this chapter.  
5.3 Methods 
5.3.1 Tissue collection 
Human testis samples were obtained from two women undergoing elective 
termination of pregnancy. Terminations were not due to foetal abnormalities and 
gestation was determined by ultrasound scan and measurement of foot length. 
Ethical approval for obtaining tissue was given by South East Scotland Research 
ethics committee and NRES committee North East-Newcastle and North Tyneside 
with written and informed consent provided by the pregnant women. Samples were 
taken from foetuses at 11 weeks and 13 weeks + 2 days of gestation.  
5.3.2 Genotyping SRY human foetal gonads 
Genotyping for the SRY gene of human tissue was performed to confirm the sex of 
the gonads. This was performed prior to collection at the Centre for Reproductive 
Health, using previously documented protocols (Gaskell et al., 2004).  
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5.3.3 Preparation of human tissue for culture 
Human testis samples were transferred on ice in transport medium, composed of 
Leibowitz L-15 solution supplemented with 10% foetal calf serum; 1% non-essential 
amino acids and 1% penicillin-streptomycin, and dissected into pieces of 
approximately 0.5 mm3. Some pieces were fixed for 90 min in 10% NBF as day 0 
controls and others placed into culture.  
5.3.4 Culture of human foetal testis 
25 µl of the enriched medium (see 2.5.2) was placed on the lid of a Petri dish and 
each piece of tissue placed in the droplet. The lid was then inverted so the tissue 
sunk to the bottom of the drop.    
5.3.4.1 First trimester testis 
On the second day of culture, testis fragments were either transferred to new 
medium, or to new medium, that had been spiked with 0.05 µg ml-1 of DOX. After 
24 hours all pieces were transferred to new drops of fresh medium (Day 3). For the 
final day in culture (Day 4) medium was supplemented with 15 µg ml-1 BrdU 
(Sigma Aldrich Ltd., UK).  
5.3.4.2 Second trimester testis 
On the second day of culture testis fragments were transferred to new medium or to 
medium spiked with CIS (0.5 µg ml-1, high; 0.05 µg ml-1, low) or DOX (0.1 µg ml-1, 
high; 0.01 µg ml-1, low). Lower doses than in the mouse study were chosen due to 
total depletion of germ cells in the mouse. After 24 hours all pieces were transferred 
to new drops of fresh medium (Day 3). Pieces were transferred to new drops every 
other day. Fragments were fixed on Day 4, Day 8 or Day 14 of culture.  
15 µg ml-1 BrdU was added to the culture for the final 24 hours for pieces fixed on 
Day 4 and 8 but this was not available for those fixed on Day 14 due to personal 
commitments and therefore has not been analysed here. 
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All tissue was washed in DPBS before being fixed as described (2.4). Between one 
and three fragments were cultured at each time point and concentration of CIS or 
DOX.  
5.3.5 Haematoxylin and eosin 
H&E staining was performed as described (2.5). 
5.3.6 Immunohistochemistry  
Immunohistochemistry was performed as described (2.6) using antibody 
combinations detailed in Table 5.1 except for OCT4 and MAGE-A4 double 
immunofluorescence which was performed over three days with only a single 
antibody added each day using protocol detailed below.  
 
Following antigen retrieval in a pressure cooker with 0.01 M citrate buffer, an 
endogenous peroxidase block of 3% (v/v) H2O2 in methanol for 30 min was 
performed and sections were washed twice in tris buffered saline (TBS; 0.05 M Tris 
and 0.85% NaCl pH 7.4) for 5 min. Sections were incubated in blocking serum 
composed of 20% normal chicken serum diluted in TBS containing 5% (w/v) BSA for 
30 min before incubation with MAGE-A4 at 1:200 overnight at 4 °C in a humidified 
chamber. Slides were washed twice in TBS, then sections were incubated with 
chicken anti-mouse peroxidase diluted at 1:200 for 30 min, followed by two TBS 
washes for 5 min and subsequently kept in the dark. Tyramide signal amplification 
kit (Perkin Elmer, UK) was used as the visualisation reagent at 1:50 for 10 min. 
Slides were washed in TBS for 5 min before being placed in citrate buffer and 
microwaved for 2.5 min. Sections were left to cool for 30 min and then incubated 
again in blocking serum, OCT4 at 1:200 (Abcam, UK), Chicken anti-goat Peroxidase 
at 1:200 and Tyramide as described previously. Slides were then counterstained 
with DAPI and washed in TBS before being mounted with PermaFluor mounting 
medium. 
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5.3.7 Image acquisition 
Images were taken as described (2.7). 
5.4 Results 
Two human foetal testis samples were examined. One was from a late first trimester 
testis (11 weeks gestation), which was forming seminiferous cords during the 
culture period. The second was from an early second trimester testis (13 weeks 
gestation) and had already formed cords.  
5.4.1 First trimester testis 
5.4.1.1 Culture of first trimester testis supports cord formation  
Testis fragments from the first trimester testis (week 11 of pregnancy) were cultured 
for four days. The tissue initially had a disorganised cell distribution with only the 
occasional clearly marked cord to having many cords surrounded by a flattened 
layer of PTMs (Fig. 5.1). No obvious morphological differences were seen between 
the control cultured tissue and that treated with a low dose of DOX.   




Figure 5.1 H&E culture of 11 week human foetal testis. Scale bars = 100 μm. 
5.4.1.2 Evidence of germ cell on exposure to low dose DOX 
To examine if low dose DOX caused depletion of the germ cell population, 
immunohistochemical analysis for MVH and BrdU was carried out in the same 
manner as for the mouse tissue reported earlier (see Chapter 4). There were very 
few cells clearly positive for MVH in any of the sections analysed, along with a lot 
of low level staining in the cords (Fig. 5.2). This made it impossible to make any firm 
conclusions. MVH would only mark the differentiated germ cell population and 
therefore is not giving a complete picture of the germ cell component of the tissue. 
Because of this, immunohistochemistry was carried out to examine the expression of 
OCT4, which marks the immature gonocytes and MAGE-A4, marking the more 
differentiated germ cells. There were very few germ cells in total when both OCT4 
and MAGE-A4 were examined, but overall, expression did not appear to be affected 
by DOX (Fig. 5.3).  




Figure 5.2 Immunohistochemical analysis for BrdU and MVH in first trimester 
testis culture. Occasional germ cells were positive for MVH (red) and were proliferating 
(BrdU; green). White arrows indicate MVH-positive germ cells. Pre-culture control was not 
given BrdU and therefore only MVH can be seen. Sections were counterstained with DAPI 
(blue). Scale bars = 50 μm. 
 
Figure 5.3 Expression of OCT4 and MAGE-A4 in first trimester testis culture. 
Only a few germ cells positive for OCT4 (red) or MAGE-A4 (green) could be seen in any of 
the fragments. White arrows mark OCT4-positive cells, yellow arrow marks MAGE-A4-
positive cell and white arrowheads mark cells positive for both OCT4 and MAGE-A4. 
Sections were counterstained with DAPI (blue). Scale bars = 50 µm. 
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5.4.1.3 Somatic cells 
The somatic cells in the testis were examined through expression of SOX9 in the 
Sertoli cells, but no clear differences in numbers were observed in any of the tissue, 
but appeared more organised in the cultured tissue due to the formation of cords 
(Fig. 5.4). COUPTFII, marking the interstitial cells appeared unaffected by culture in 
appearance or by exposure to a low dose of DOX and there was an apparent 
increase in CC3 expression following low dose DOX compared to control (Fig. 5.5).  
 
 
Figure 5.4 Expression of SOX9 in first trimester testis culture. SOX9 (green) was 
used to visualise Sertoli cells. No obvious depletion was observed in the treated tissue. 
Sections were counterstained with DAPI (blue). Scale bars = 50 µm. 




Figure 5.5 Expression of COUPTFII and CC3 in first trimester testis culture. 
COUPTFII expression (red) was expressed in the majority of interstitial cells in all sections 
examined. Occasional CC3-positive cells (green) were found in the cultured sections with 
an apparent increase in the treated tissue. Scale bars = 50 µm. 
5.4.2 Second trimester testis 
5.4.2.1 Second trimester human foetal testis tissue can be cultured for 14 days 
The second trimester human testis was cultured for up to 14 days with pieces fixed 
at 4, 8 and 14 days after being placed in culture. Even after 14 days the tissue looked 
healthy with many preserved cords. The interstitial compartment appeared smaller 
by the end of culture with a much higher cell density (Fig. 5.6). As the tissue 
appeared to culture well for 14 days this time-point was used to examine the effects 
of CIS or DOX. At the low dose of CIS or DOX the tubules remained intact whereas, 
at the high dose of CIS or DOX there was a loss of cords and cell density (Fig. 5.7).  
 




Figure 5.6 H&E of second trimester testis tissue after 14 days in culture. Tissue 
appears healthy. Scale bars = 100 µm. 
 
 
Figure 5.7 H&E of 14 day culture of second trimester testis in presence of CIS 
or DOX. The sections treated with A) low CIS or B) low DOX showed normal 
morphology. At the high dose of C) CIS and F) DOX there was a loss of cell density with 
fewer tubules and many pyknotic cells. Scale bars = 100 µm.  
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5.4.2.2 Germ cells 
The germ cell population was examined by immohistochemistry for MVH and 
OCT4.  These antibodies would detect both immature gonocytes (OCT4) and the 
differentiating prespermatogonia (MVH). Before culture the tissue contained many 
OCT4-positive germ cells and weak MVH staining (Fig. 5.8A–B). Over 14 days of 
culture there were fewer OCT4-positive germ cells and MVH became much stronger 
suggesting either the tissue progressed through normal development or the OCT4-
positive gonocytes were not supported by the culture (Fig. 5.8C–D). OCT4-positive 
germ cells were only present at the lowest dose of CIS, but in all other treatments 
there were none remaining (Fig. 5.9A, Fig. 5.9C, Fig. 5.9E, and Fig. 5.9G). MVH-
positive germ cells were still present in the tissue treated with low dose CIS, but at 
the high dose of CIS and both the low and high dose of DOX there appeared to be a 
loss of these cells. However, there were always some MVH-positive germ cells (Fig. 
5.9C–F). Overall, it would seem that the OCT4-positive immature germ cells may be 
more sensitive to CIS and DOX than the more mature MVH-expressing germ cells.  
 




Figure 5.8 Germ cells in the second trimester testis cultured for 14 days. MVH 
(red) or OCT4 (green) expression counterstained with DAPI (blue) in A, B) pre-cultured 
testis fragment or C, D) 14 day control culture Scale bars = 100 µm. 




Figure 5.9 Germ cells in second trimester testis cultured for 14 days. OCT4 
(green) or MVH (red) expression counterstained with DAPI (blue) in fragments exposed to 
A, B) low and C, D) high CIS or E, F) low and G, H) high DOX. White arrows indicate 
MVH-positive germ cells. Scale bar = 100 µm. 
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5.4.2.3 Somatic cells 
There was no apparent difference between the appearances of SOX9-positive Sertoli 
cells in any of the sections examined (Fig. 5.10). There was a change in SOX9 
distribution in the tissue treated with high dose DOX, but this appeared to be due to 
disruption in cords rather than a change in expression. COUPTFII was still 
expressed in the majority of the interstitial cells following culture and in testis 
fragments exposed to the lowest dose of CIS (Fig. 5.11). However, there appeared to 
be fewer COUPTFII-positive cells following exposure to CIS (high dose) or DOX 
(low and high dose) indicating a loss of interstitial cells. There were very few CC3-
positive cells in any of the sections examined.  
  




Figure 5.10 Immunohistochemistry for SOX9 in second trimester testis 
cultured for 14 days. SOX9 (green) expression counterstained with DAPI (blue) in A) 
pre-cultured testis fragment, B) 14 day control culture along with fragments exposed to 
C,E) CIS and D,F) DOX at a low and high dose respectively. Scale bars = 100 µm. 




Figure 5.11 Immunohistochemistry for COUPTFII and CC3 in second trimester 
testis cultured for 14 days. COUPTFII (red) and CC3 (green) expression counterstained 
with DAPI (blue) in A) pre-cultured testis fragment and B) 14 day control culture. 
Fragments were exposed to C,E) CIS and D,F) DOX at a low and high dose respectively. 
Scale bars = 100 µm. 
  




Two human foetal testis samples were used to provide preliminary data on the 
effect of chemotherapy on the human testis.  
 
The first trimester sample formed seminiferous cords during the culture period and 
supported survival of all cell types. Due to the small size of the sample only one 
concentration of DOX, was examined and it appeared not to have an effect on the 
germ cells or somatic cells in the testis. This dose was the lowest dose examined in 
Chapter 4 that resulted in a depletion of the germ cell population. This sample is the 
least relevant to human patients as it is still forming tubules and the germ cells are 
immature. Combined with the small size, meaning limited number of fragments 
available, it is suggested to continue this work with testes taken later in gestation.  
 
The second trimester culture of up to 14 days allowed examination of the medium 
term effects of chemotherapy on the human testis. The 14 days culture supported 
germ cell development with a reduction in OCT4-positive gonocytes and an 
increase in MVH-positive prespermatogonia. This is indicative of normal germ cell 
development in the second trimester human testes (Anderson et al., 2007, Mitchell et 
al., 2008). The culture also maintained the somatic cells in the testis and showed 
little apoptosis. 
 
The germ cell population in the human foetal testis tissue was not completely 
depleted even at doses of CIS or DOX that had a dramatic effect on the mouse testis. 
As chemotherapeutics predominantly target dividing cells it is vital to know which 
cells are proliferating in the human foetal testis. In human foetal testis samples and 
foetal tissue grafted into immunodeficient mice there is a much higher proliferation 
index in the OCT4-positive germ cells than the more differentiated MAGE-A4 cells 
(Mitchell et al., 2010). This would fit with the observation of a total depletion of 
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OCT4-positive gonocytes, but preservation of the MVH-positive germ cells.  
However, the human testis is unlikely to be exposed to chemotherapy during 
pregnancy and treatment during infancy is relatively rare. This model was 
developed to infer the effect of chemotherapy in prepubertal patients treated for 
cancer. It is therefore crucial to know details of the germ cell population of the testis 
throughout childhood, and whether the germ cells are proliferating. In the mouse 
there is a big increase in proliferation in the neonatal period as the germ cells 
resume proliferation at approximately pnd5 (Jarvis et al., 2005), but there is little 
data about when differentiated pre-spermatogonia resume mitosis in the human 
testes. Analysis of postnatal testis samples suggests that germ cells are highly 
proliferative for the first year of life (Berensztein et al., 2002), which corresponds 
with the observation that there are a few remaining OCT4-positive cells (Rajpert‐De 
Meyts et al., 2004), but the majority are negative by this age. Data from the 
marmoset suggest that although there is proliferation following birth (Kelnar et al., 
2002), this is at a lower level than during the foetal period (Mitchell et al., 2008), 
implying the postnatal human testis may be even less susceptible than the foetal 
tissue presented here.  
 
If this study was to be continued it would be better to image both germ cell 
populations in a single photomicrograph. This would allow total germ cells to be 
counted, while avoiding any double counting. The OCT4 and MAGE-A4 double 
immunofluorescence would be suitable for this. Ratios between OCT4-positive germ 
cells and MAGE-A4-positive cells tissue could also be calculated and compared to 
tissue fixed at different gestational ages to fully explore if the cultured tissue is 
following a normal developmental progression.  
 
When the somatic cells were examined the supporting Sertoli cells appeared 
unaffected by either CIS or DOX, whereas, there was a loss of interstitial cells 
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expressing COUPTFII. These COUPTFII expressing cells include Leydig cells and, 
the ALSCs (Kilcoyne et al., 2014) and therefore any loss of these cells could have a 
profound effect on testosterone production in later life. This was a surprising 
finding as it is believed that the Leydig cells are fairly resistant to chemotherapeutic 
damage in comparison to germ cells (Howell and Shalet, 2001). Nevertheless, there 
is evidence that there is increasing risk of hypogonadism in childhood cancer 
survivors, which can lead to depression, impaired libido and fatigue (Romerius et 
al., 2009). The interstitial population could be further examined by co-staining 
COUPTFII with 3β-HSD to distinguish the ALSCs (COUPTFII+/3β-HSD–) from the 
other interstitial populations to examine if a specific cell type was lost. Testosterone 
could be measured in the medium to see if this was affected by exposure to CIS or 
DOX. However, this would only be measuring the testosterone capacity of the 
immature Leydig cells and not the ALSCs that differentiate and proliferate during 
postnatal life to maintain androgen production throughout adulthood (Griswold 
and Behringer, 2009).  
 
If more time were available it would be interesting to examine the tissue fixed on 
day four. This could be used to compare the longer term culture shown here to any 
initial damage present at day four, which would be similar to the mouse tissue 
presented earlier. This could determine if the germ cells surviving here represent 
recovery following a more substantial initial depletion.  
 
In conclusion, these results appear to suggest that CIS or DOX affect primarily the 
undifferentiated germ cell population along with the interstitial cells. These cultures 
provide a starting point for further investigations into the effect of chemotherapy on 
the human foetal testis. 
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Chapter 6. General discussion 
6.1 Summary of results 
Initially the culture of postnatal mouse testis tissue was investigated to find the 
most suitable method for studying the effect of chemotherapy on the neonatal 
mouse testis. The results show that postnatal mouse testis tissue can be cultured for 
4 days. Culturing was most successful using a membrane to allow the tissue to sit at 
the media—air interface and using a minimal medium. This culturing technique 
retained many of the aspects of neonatal development, although improvements 
could be made as there were fewer germ cells and Sertoli cells than would be found 
in vivo. The main focus of the project was to examine the effect of chemotherapy on 
the prepubertal testis. This was achieved using the developed in vitro culture of 
neonatal mouse testis. Tissue was exposed to three chemotherapeutic agents given 
to prepubertal patients: the CYP metabolite PM, CIS, and DOX. The tissue was 
exposed for 24 h and then examined two days later. All three chemotherapeutic 
agents showed a specific loss of germ cells indicating that fertility may be lost. 
However, at the doses examined, exposure to CIS and DOX even at lowest doses 
resulted in loss of the majority of germ cells whereas; PM only resulted in depletion 
at the highest dose. The loss of germ cells occurred without affecting Sertoli or 
interstitial cell numbers. There was little apoptosis by the end of the culture period, 
but considerably more when the tissue was fixed 24 h after the drug was added to 
the culture, indicating that the death of the germ cells happened earlier in the 
culture and that the dying cells were no longer present by the end of the culture 
period.  
 
Finally, the culture of human foetal testis tissue was examined as far as was able, 
after obtaining only two samples: one from late first trimester testis and the other 
from the early second trimester. This cultured well in hanging drops for up to 14 
days using recently developed methods (Jorgensen et al., 2015). When exposed to 
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DOX the first trimester testis did not appear affected, although a lower dose was 
used than in the mouse studies. The second trimester testis showed a complete loss 
of the immature germ cells on exposure to CIS and DOX whereas, there was only a 
reduction in the mature germ cells on exposure to DOX or at the highest dose of 
CIS. The interstitium also appeared to lose cells on exposure to DOX and the highest 
dose of CIS, which was not seen in the postnatal mouse testis. Using an in vitro 
model to assess chemotherapy induced damage has its strengths and weaknesses. It 
allows the isolation of effects directly on the testis without interference from other 
systems and reduces the number of animals used. However, as discussed in chapter 
4 the doses used were based on patient serum drug levels and therefore may not be 
relevant to the doses distributed to the testis. Additionally, in the testis, the 
seminiferous tubules do not have a direct blood supply, being separated by a 
basement membrane. In this study the testis was cut into small pieces exposing the 
seminiferous tubules more directly to the chemotherapeutic agents than would 
occur in vivo and therefore potentially resulting in a higher level of exposure.  
 
In conclusion, the results presented here demonstrate the culture of postnatal mouse 
and embryonic human testis tissue and that the primary effect of CYP, CIS and DOX 
is through loss of the germ cells.  
6.2 Further work 
6.2.1 Investigation of long term damage 
The model examined tissue approximately 72 hours after the addition of the 
chemotherapeutic agents. At this time point exposure to all concentrations of CIS or 
DOX and the highest concentrations of PM resulted in depletion of the majority of 
the germ cells from the testis. However, in human prepubertal patients fertility is 
only relevant months to years following exposure. The testis contains SSCs, which if 
still present following exposure, could contribute to regeneration of the 
seminiferous tubules. A few dividing germ cells were present at the end of culture, 
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which indicates there could be potential for regeneration. It has been shown that 
even a very small number of stem cells can contribute to the regeneration of 
spermatogenesis (Brinster, 2002). This long term damage could be difficult to assess 
in an in vitro culture system as it is hard to maintain good tissue integrity over a 
long period of time. However, recently, testis tissue culture has been achieved for 
up to 60 days (Sato et al., 2011). An alternative model would be grafting the testis 
tissue following a short culture into immuno-deficient mice.  Grafts from neonatal 
mice have been known to survive and complete spermatogenesis (Honaramooz et 
al., 2002). After a number of weeks the grafts could be retrieved and examined to see 
if the loss of germ cells has persisted, recovered or if there was further loss of the 
remaining cells. This could also be applied to any other model species, as xenografts 
have been established for a wide range of species, including human testis, 
recapitulating many aspects of development (Goossens et al., 2008, Mitchell et al., 
2010). Therefore, this method would be applicable for tissue that may be more 
relevant to human patients see below.  
6.2.2 Mechanism of damage 
By the time the tissue was examined, the germ cells had already died in samples 
exposed to PM, CIS or DOX, and there was little evidence of apoptosis in the tissue. 
Therefore, in order to elucidate the mechanism, it would be appropriate to examine 
the tissue earlier to observe the process of germ cell death. A time course analysis 
could be performed for this purpose. It could be achieved by fixing the tissue at a 
variety of points after the addition of the drug to examine when the germ cells are 
dying and the pathway by which this occurs. One initial culture was fixed at 24 
hours after the addition of the drug and showed that at the highest dose of DOX the 
majority of germ cells were already lost, whereas, at the highest dose of CIS there 
were still many remaining. This was the case despite the two drugs having a similar 
degree of damage two days later. This suggests that each drug may take a different 
length of time to enter the cell and cause the initial damage; or after the drug has 
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initiated the damage it may occur through different apoptotic pathways. A range of 
molecules within the apoptotic pathway could be examined at these time points to 
build up a more complete picture of the damage to the testis following exposure to 
PM, CIS or DOX. This information is vital for the informed development of 
preventative treatments.  
6.2.3 Human tissue 
The majority of work conducted here was using a neonatal mouse model. However, 
postnatal development is different for rodents and humans. The rodent does not 
have the long extended childhood, but progresses straight from the neonatal period 
into puberty, both in terms of germ cell development and Sertoli cell maturation. 
This means the time point that is more important for childhood cancer survivors is 
not well represented in the mouse. The ideal model for patients would be human 
tissue, and one such potential model was examined here using foetal testis tissue. 
Although there is not much tissue available, each culture uses only a small amount 
of tissue as every piece is cut into small fragments. Each culture can therefore use 
the same sample for both treated and control tissue. However, there are differences 
between the foetal and neonatal testis. There is little information about the 
prepubertal testis in the human. The majority of data is inferred from primate 
models such as the marmoset (Kelnar et al., 2002, Chemes, 2001). This model 
indicates that there is proliferation in the neonatal testis, but that this is lower than 
during foetal life (Mitchell et al., 2008). To be able to find the most appropriate 
model for human patients the normal development of the prepubertal testis will 
need to be more intensively studied. Samples are beginning to be obtained from 
prepubertal patients for experimental fertility preservation methods. If some of 
these samples could be used for research, then more information could be gained 
about this developmental period. It would not only inform the best models to use in 
studies on the damage of chemotherapy, but also aid in the development of fertility 
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